People Incorporated Common Stock (PPLI) Financials

$41.70 -1.85 (-4.25%)

As of 06/5/2026

Annual Income Statements for People Incorporated Common Stock

This table shows People Incorporated Common Stock's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	247	23	270	598	-1,170	266	-540	-104
Consolidated Net Income / (Loss)	292	32	269	589	-1,192	258	-533	-101
Net Income / (Loss) Continuing Operations	292	82	290	591	-1,195	295	-573	-117
Total Pre-Tax Income	306	34	244	730	-1,526	393	-715	-82
Total Operating Income	36	5.73	-538	-137	-475	-238	-29	-97
Total Gross Profit	2,032	1,962	2,019	2,403	3,302	1,700	1,620	1,583
Total Revenue	2,533	2,510	2,765	3,700	5,235	2,919	2,622	2,393
Operating Revenue	2,533	2,510	2,765	3,700	5,235	2,919	2,622	2,393
Total Cost of Revenue	501	548	745	1,296	1,934	1,219	1,002	810
Operating Cost of Revenue	501	548	745	1,296	1,934	1,219	1,002	810
Total Operating Expenses	1,996	1,957	2,557	2,540	3,776	1,938	1,648	1,681
Selling, General & Admin Expense	570	573	745	797	992	519	499	419
Marketing Expense	1,099	1,118	1,165	1,362	1,915	803	738	728
Research & Development Expense	177	133	185	231	318	238	228	196
Depreciation Expense	42	55	69	75	131	81	41	38
Amortization Expense	107	74	127	75	308	288	142	93
Impairment Charge	0.00	3.32	265	0.00	113	9.00	0.00	207
Total Other Income / (Expense), net	270	29	782	867	-1,051	631	-686	16
Interest Expense	13	12	16	34	110	137	136	120
Interest & Investment Income	0.00	0.00	841	789	-724	722	-649	119
Other Income / (Expense), net	283	40	-43	112	-218	47	99	16
Income Tax Expense	13	-47	-46	139	-331	98	-142	35
Net Income / (Loss) Discontinued Operations	-	-49	-21	-1.83	2.69	-37	40	15
Net Income / (Loss) Attributable to Noncontrolling Interest	46	9.29	-1.14	-8.56	-22	-7.63	6.57	2.56
Basic Earnings per Share	$2.90	$0.27	$3.16	$6.70	($13.55)	$3.07	($6.49)	($1.30)
Weighted Average Basic Shares Outstanding	-	-	88.77M	89.76M	88.87M	85.97M	83.28M	76.91M
Diluted Earnings per Share	$2.90	$0.27	$2.97	$6.31	($13.55)	$2.97	($6.49)	($1.30)
Weighted Average Diluted Shares Outstanding	-	-	88.77M	89.76M	88.87M	85.97M	83.28M	76.91M
Weighted Average Basic & Diluted Shares Outstanding	-	-	88.77M	89.76M	88.87M	85.97M	83.28M	76.91M

This table shows People Incorporated Common Stock's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-391	328	45	-142	-244	-199	-217	211	-22	-77	-72
Consolidated Net Income / (Loss)	-392	327	45	-141	-237	-199	-215	211	-22	-76	-71
Net Income / (Loss) Continuing Operations	-392	363	49	-145	-276	-202	-258	211	-22	-76	-2.25
Total Pre-Tax Income	-511	465	96	-185	-362	-263	-321	274	-49	2.53	-18
Total Operating Income	-33	-14	-63	-21	8.15	48	24	0.58	-20	-113	-40
Total Gross Profit	769	-569	365	381	399	475	294	385	382	451	263
Total Revenue	1,111	-388	624	634	642	721	482	587	590	646	423
Operating Revenue	1,111	-388	624	634	642	721	482	587	590	646	423
Total Cost of Revenue	342	181	259	253	243	247	187	202	207	195	160
Operating Cost of Revenue	342	181	259	253	243	247	187	202	207	195	160
Total Operating Expenses	802	-555	428	403	391	427	270	384	403	564	303
Selling, General & Admin Expense	211	-183	127	126	109	137	43	117	132	106	104
Marketing Expense	407	-421	188	177	183	190	157	186	188	173	133
Research & Development Expense	80	-13	63	53	54	58	36	50	49	46	40
Depreciation Expense	34	-55	13	9.12	8.88	10	11	7.98	9.00	8.59	7.31
Amortization Expense	61	118	37	37	36	32	22	23	24	23	19
Total Other Income / (Expense), net	-478	479	159	-164	-371	-312	-345	273	-29	116	22
Interest Expense	40	20	35	34	35	32	28	37	28	27	26
Interest & Investment Income	-463	513	164	-179	-346	-287	-324	307	17	119	34
Other Income / (Expense), net	25	-14	30	50	10	7.71	7.63	2.83	-18	24	14
Income Tax Expense	-119	102	47	-40	-86	-62	-62	63	-27	78	-16
Net Income / (Loss) Discontinued Operations	-	-	-4.47	3.23	39	2.30	44	0.00	0.00	-0.03	-68
Net Income / (Loss) Attributable to Noncontrolling Interest	-1.48	-1.10	-0.06	0.77	6.27	-0.41	2.24	-0.82	0.14	1.00	1.21
Basic Earnings per Share	($4.72)	$4.14	$0.52	($1.71)	($2.93)	($2.37)	($2.64)	$2.64	($0.27)	($1.03)	($0.94)
Weighted Average Basic Shares Outstanding	85.85M	85.97M	86.09M	86.12M	86.27M	83.28M	79.84M	80.16M	77.43M	76.91M	74.38M
Diluted Earnings per Share	($4.72)	$4.19	$0.51	($1.71)	($2.93)	($2.36)	($2.64)	$2.57	($0.27)	($0.96)	($0.94)
Weighted Average Diluted Shares Outstanding	85.85M	85.97M	86.09M	86.12M	86.27M	83.28M	79.84M	80.16M	77.43M	76.91M	74.38M
Weighted Average Basic & Diluted Shares Outstanding	85.85M	85.97M	86.09M	86.12M	86.27M	83.28M	79.84M	80.16M	77.43M	76.91M	74.38M

This table details how cash moves in and out of People Incorporated Common Stock's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	254	-46	2,634	-3,027	-690	-291	945	-820
Net Cash From Operating Activities	369	275	113	119	-83	77	192	61
Net Cash From Continuing Operating Activities	369	275	113	119	-83	77	192	64
Net Income / (Loss) Continuing Operations	292	82	290	591	-1,195	295	-573	-117
Consolidated Net Income / (Loss)	292	32	269	589	-1,192	258	-533	-101
Net Income / (Loss) Discontinued Operations	-	-49	-21	-1.83	2.69	-37	40	15
Depreciation Expense	42	55	69	75	131	81	41	38
Amortization Expense	107	74	127	75	308	288	142	93
Non-Cash Adjustments To Reconcile Net Income	-76	181	-228	-701	1,335	-592	682	164
Changes in Operating Assets and Liabilities, net	3.15	-117	-144	79	-661	5.67	-99	-113
Net Cash From Discontinued Operating Activities	-	-	-	-	-	-	-	-2.76
Net Cash From Investing Activities	-45	-250	-1,872	-2,908	-495	-41	327	-405
Net Cash From Continuing Investing Activities	-45	-250	-1,872	-2,908	-495	-41	327	-405
Purchase of Property, Plant & Equipment	-55	-95	-61	-90	-140	-94	-15	-19
Acquisitions	-66	-28	-685	-2,700	-244	0.00	0.00	-427
Purchase of Investments	-109	-254	-1,671	-24	-237	-547	-222	0.00
Sale of Property, Plant & Equipment	-	-	0.00	1.22	9.78	29	13	17
Divestitures	-	166	26	16	91	11	177	11
Sale and/or Maturity of Investments	171	-30	530	225	19	549	389	14
Other Investing Activities, net	13	-9.09	-12	-336	6.12	9.90	-15	-1.59
Net Cash From Financing Activities	-198	127	4,203	1,116	-113	-206	-77	-451
Net Cash From Continuing Financing Activities	-198	127	4,203	1,116	-113	-206	-77	-451
Repayment of Debt	-19	-20	-33	-262	-26	-30	-70	-1,447
Repurchase of Common Equity	0.00	-57	-64	-35	-93	-166	0.00	-315
Issuance of Debt	2.50	0.00	500	1,600	0.00	0.00	7.96	1,391
Other Financing Activities, net	-186	229	2,395	-156	-27	-11	-15	-80
Effect of Exchange Rate Changes	-	-	-	-	-	-	-	0.76
Other Net Changes in Cash	127	-199	190	-1,354	-	-121	502	-30

This table details how cash moves in and out of People Incorporated Common Stock's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-73	-126	209	391	213	132	-639	-65	-88	-29	133
Net Cash From Operating Activities	14	-65	40	20	64	68	-2.69	-2.75	30	37	15
Net Cash From Continuing Operating Activities	14	-65	40	20	64	68	-27	-2.75	30	37	9.96
Net Income / (Loss) Continuing Operations	-392	363	49	-145	-276	-202	-258	211	-22	-76	-2.25
Consolidated Net Income / (Loss)	-392	327	45	-141	-237	-199	-215	211	-22	-76	-71
Net Income / (Loss) Discontinued Operations	-	-	-4.47	3.23	39	2.30	44	-	-	-0.03	-68
Depreciation Expense	34	-55	13	9.12	8.88	10	11	7.98	9.00	8.59	7.31
Amortization Expense	61	118	37	37	36	32	22	23	24	23	19
Non-Cash Adjustments To Reconcile Net Income	513	-572	-163	163	369	312	284	-261	38	101	-10
Changes in Operating Assets and Liabilities, net	-201	81	104	-44	-74	-85	-87	16	-18	-20	-3.99
Net Cash From Discontinued Operating Activities	-	-	-	-	-	-	25	-	-	-	5.42
Net Cash From Investing Activities	-76	62	185	59	58	25	-375	1.32	3.26	-33	261
Net Cash From Continuing Investing Activities	-76	62	185	59	58	25	-375	1.32	3.26	-33	261
Purchase of Property, Plant & Equipment	-18	33	-2.91	-3.45	-3.40	-5.26	-4.14	-4.46	-4.88	-5.21	-7.96
Acquisitions	-	-	0.00	-	-	-	-387	-	-	-40	-37
Divestitures	5.70	1.68	160	2.50	11	3.61	10	-0.24	-	1.50	303
Sale and/or Maturity of Investments	60	150	138	135	90	27	5.25	3.24	3.46	1.99	0.00
Other Investing Activities, net	0.00	-	1.20	-1.20	-15	0.05	0.13	2.66	0.67	-4.92	2.60
Net Cash From Financing Activities	-11	-1.43	-16	-8.20	-13	-40	-234	-65	-120	-32	-141
Net Cash From Continuing Financing Activities	-11	-1.43	-16	-8.20	-13	-40	-234	-65	-120	-32	-141
Repayment of Debt	-7.50	-7.36	-7.65	-7.52	-7.56	-47	-9.41	-1,426	-8.02	-3.96	-6.12
Repurchase of Common Equity	-	3.40	0.00	-	-	-	-179	-21	-100	-15	-124
Issuance of Common Equity	-	-	-	-	-	-	0.00	-	-	-	6.54
Other Financing Activities, net	-3.74	2.53	-8.25	-0.68	-5.69	-0.36	-45	-9.50	-12	-13	-18
Effect of Exchange Rate Changes	-	-	-	-	-	-	0.36	1.25	-0.96	0.11	-1.41
Other Net Changes in Cash	-	-	0.96	320	104	78	-2.76	-	-	-	5.36

This table presents People Incorporated Common Stock's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	4,097	9,162	12,303	10,394	10,371	9,689	7,195
Total Current Assets	1,229	4,119	3,076	2,561	2,241	2,485	1,545
Cash & Equivalents	840	3,366	2,119	1,417	1,297	1,382	941
Accounts Receivable	182	258	696	608	537	483	417
Other Current Assets	152	140	242	297	257	125	102
Other Current Nonoperating Assets	-	130	-	-	-	495	85
Plant, Property, & Equipment, net	305	275	571	511	455	313	284
Total Noncurrent Assets	2,563	4,767	8,656	7,322	7,675	6,890	5,366
Long-Term Investments	348	298	328	2,496	3,303	2,681	2,811
Goodwill	1,617	1,660	3,227	3,030	3,024	1,993	1,508
Intangible Assets	350	395	1,415	1,170	875	554	394
Other Noncurrent Operating Assets	248	2,148	3,687	626	473	325	225
Other Noncurrent Nonoperating Assets	-	267	-	-	-	1,337	427
Total Liabilities & Shareholders' Equity	4,097	9,162	12,303	10,394	10,371	9,689	7,195
Total Liabilities	1,048	1,779	4,535	3,794	3,583	3,384	2,406
Total Current Liabilities	585	751	1,382	1,080	950	886	561
Short-Term Debt	14	0.00	30	30	30	35	25
Accounts Payable	72	89	203	133	106	54	37
Accrued Expenses	320	340	983	760	672	509	404
Current Deferred Revenue	179	138	165	157	143	57	19
Other Current Nonoperating Liabilities	-	184	-	-	-	232	77
Total Noncurrent Liabilities	463	1,028	3,153	2,714	2,632	2,498	1,845
Long-Term Debt	232	712	2,046	2,020	1,993	1,435	1,401
Noncurrent Deferred & Payable Income Tax Liabilities	44	79	386	76	165	154	209
Other Noncurrent Operating Liabilities	180	234	721	618	475	373	226
Other Noncurrent Nonoperating Liabilities	-	2.97	-	-	-	536	8.66
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	44	232	19	27	33	25	25
Total Equity & Noncontrolling Interests	3,005	7,151	7,749	6,573	6,755	6,279	4,764
Total Preferred & Common Equity	2,535	6,598	7,175	5,932	6,078	5,578	4,734
Total Common Equity	2,535	6,598	7,175	5,932	6,078	5,578	4,734
Common Stock	0.00	5,910	6,266	6,295	6,340	6,381	5,960
Retained Earnings	0.00	694	905	-265	0.92	-539	-643
Treasury Stock	-	-	0.00	-85	-252	-252	-571
Accumulated Other Comprehensive Income / (Loss)	-12	-6.17	4.40	-13	-11	-11	-12
Noncontrolling Interest	470	553	574	641	677	701	30

This table presents People Incorporated Common Stock's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	10,549	10,018	10,360	10,204	9,837	7,187	7,360	7,188	6,820
Total Current Assets	2,198	2,212	2,311	2,368	2,401	1,694	1,602	1,515	1,551
Cash & Equivalents	1,327	1,252	1,507	1,602	1,720	1,159	1,094	1,005	1,112
Accounts Receivable	522	519	464	490	478	392	376	397	329
Other Current Assets	234	267	204	189	178	143	132	113	109
Other Current Nonoperating Assets	-	-	-	-	-	0.00	0.00	0.00	0.00
Plant, Property, & Equipment, net	495	478	425	409	401	308	305	299	286
Total Noncurrent Assets	7,856	7,328	7,624	7,427	7,036	5,185	5,454	5,373	4,984
Long-Term Investments	432	432	3,458	3,278	2,978	2,339	2,635	2,653	2,878
Goodwill	3,033	3,022	2,879	2,879	2,882	1,993	1,993	1,993	1,508
Intangible Assets	1,062	1,000	830	794	758	531	508	484	375
Other Noncurrent Operating Assets	3,329	2,874	457	477	418	322	318	243	223
Other Noncurrent Nonoperating Assets	-	-	-	-	-	0.00	0.00	0.00	0.00
Total Liabilities & Shareholders' Equity	10,549	10,018	10,360	10,204	9,837	7,187	7,360	7,188	6,820
Total Liabilities	3,737	3,572	3,510	3,479	3,354	2,424	2,398	2,344	2,226
Total Current Liabilities	1,034	1,023	855	885	875	627	559	592	420
Short-Term Debt	30	30	34	39	43	42	21	23	25
Accounts Payable	128	144	84	77	80	47	48	43	36
Accrued Expenses	716	684	609	649	634	459	425	462	339
Current Deferred Revenue	161	166	128	121	117	79	65	64	21
Other Current Nonoperating Liabilities	-	-	-	-	-	0.00	0.00	0.00	0.00
Total Noncurrent Liabilities	2,703	2,549	2,655	2,594	2,479	1,797	1,839	1,752	1,806
Long-Term Debt	2,006	2,000	1,982	1,971	1,960	1,420	1,412	1,407	1,396
Noncurrent Deferred & Payable Income Tax Liabilities	178	61	211	172	85	73	135	107	193
Other Noncurrent Operating Liabilities	518	489	462	451	435	304	292	239	217
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	0.00	0.00	0.00	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	35	33	33	29	29	25	25	25	12
Total Equity & Noncontrolling Interests	6,778	6,412	6,817	6,696	6,455	4,737	4,938	4,818	4,582
Total Preferred & Common Equity	6,117	5,741	6,133	6,008	5,760	4,714	4,911	4,790	4,549
Total Common Equity	6,117	5,741	6,133	6,008	5,760	4,714	4,911	4,790	4,549
Common Stock	6,312	6,327	6,346	6,364	6,362	5,914	5,920	5,923	5,974
Retained Earnings	64	-327	46	-96	-340	-756	-544	-566	-715
Treasury Stock	-253	-252	-252	-252	-252	-433	-454	-555	-696
Accumulated Other Comprehensive Income / (Loss)	-6.90	-6.58	-6.89	-6.47	-9.61	-11	-11	-12	-14
Noncontrolling Interest	661	672	684	688	695	24	26	28	33

This table displays calculated financial ratios and metrics derived from People Incorporated Common Stock's official financial filings.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-0.91%	10.14%	33.82%	41.51%	-44.24%	-10.18%	-8.73%
EBITDA Growth	0.00%	-62.42%	-318.62%	132.41%	-303.67%	170.04%	42.07%	-80.38%
EBIT Growth	0.00%	-85.49%	-1,355.33%	95.65%	-2,646.82%	72.40%	136.55%	-216.03%
NOPAT Growth	0.00%	-60.20%	-4,777.83%	82.62%	-199.51%	46.32%	88.75%	-239.69%
Net Income Growth	0.00%	-88.99%	734.56%	119.29%	-302.46%	121.66%	-306.46%	80.97%
EPS Growth	0.00%	-90.69%	1,000.00%	112.46%	-314.74%	121.92%	-318.52%	79.97%
Operating Cash Flow Growth	0.00%	-25.47%	-58.82%	4.87%	-169.63%	193.39%	148.91%	-68.16%
Free Cash Flow Firm Growth	0.00%	0.00%	-20.76%	-38.15%	172.97%	-89.94%	443.67%	-90.24%
Invested Capital Growth	0.00%	0.00%	89.68%	84.61%	-39.05%	-9.67%	-34.82%	-7.71%
Revenue Q/Q Growth	0.00%	0.00%	9.22%	13.89%	1.69%	-35.89%	-11.38%	-34.50%
EBITDA Q/Q Growth	0.00%	0.00%	-987.53%	231.27%	-39.91%	479.11%	-11.67%	-85.29%
EBIT Q/Q Growth	0.00%	0.00%	-150.06%	88.49%	-25.11%	51.42%	463.47%	-176.01%
NOPAT Q/Q Growth	0.00%	0.00%	-85.25%	-79.54%	-1.23%	14.75%	74.78%	-210.09%
Net Income Q/Q Growth	0.00%	0.00%	215.12%	-45.91%	-1.52%	428.44%	-7,215.91%	54.91%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-47.63%	0.00%	0.00%	-10,916.67%	51.85%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	234.76%	-75.79%	57.06%	-52.25%	12.48%	-75.97%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-39.05%	202.62%	290.21%	-49.74%	-88.77%
Invested Capital Q/Q Growth	0.00%	0.00%	91.48%	62.62%	-32.80%	-38.62%	-29.65%	-6.55%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	80.22%	78.18%	73.04%	64.96%	63.06%	58.24%	61.77%	66.16%
EBITDA Margin	18.48%	7.01%	-13.91%	3.37%	-4.85%	6.09%	9.63%	2.07%
Operating Margin	1.41%	0.23%	-19.45%	-3.70%	-9.07%	-8.14%	-1.09%	-4.07%
EBIT Margin	12.58%	1.84%	-20.99%	-0.68%	-13.23%	-6.55%	2.66%	-3.39%
Profit (Net Income) Margin	11.54%	1.28%	9.72%	15.92%	-22.78%	8.85%	-20.34%	-4.24%
Tax Burden Percent	95.68%	93.78%	110.00%	80.70%	78.13%	65.72%	74.59%	123.88%
Interest Burden Percent	95.90%	74.25%	-42.08%	-2,894.56%	220.38%	-205.62%	-1,023.56%	101.05%
Effective Tax Rate	4.32%	-137.98%	-18.72%	19.04%	0.00%	24.98%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	1.30%	-20.92%	-1.95%	-5.60%	-4.17%	-0.60%	-2.68%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-2.64%	-62.82%	-39.02%	63.40%	-22.25%	15.48%	-1.57%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.82%	26.07%	9.73%	-11.00%	8.03%	-7.55%	0.85%
Return on Equity (ROE)	0.00%	2.11%	5.15%	7.78%	-16.60%	3.86%	-8.15%	-1.83%
Cash Return on Invested Capital (CROIC)	0.00%	-198.70%	-82.83%	-61.41%	42.92%	5.99%	41.56%	5.34%
Operating Return on Assets (OROA)	0.00%	1.13%	-8.75%	-0.23%	-6.10%	-1.84%	0.70%	-0.96%
Return on Assets (ROA)	0.00%	0.79%	4.05%	5.49%	-10.51%	2.49%	-5.32%	-1.21%
Return on Common Equity (ROCE)	0.00%	1.76%	4.51%	7.07%	-15.14%	3.46%	-7.25%	-1.70%
Return on Equity Simple (ROE_SIMPLE)	0.00%	1.27%	4.07%	8.21%	-20.10%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	34	14	-638	-111	-332	-178	-20	-68
NOPAT Margin	1.35%	0.54%	-23.09%	-3.00%	-6.35%	-6.11%	-0.77%	-2.85%
Net Nonoperating Expense Percent (NNEP)	0.00%	3.94%	41.90%	37.07%	-69.00%	18.09%	-16.08%	-1.11%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-3.85%	-2.03%	-0.26%	-1.10%
Cost of Revenue to Revenue	19.78%	21.82%	26.96%	35.04%	36.94%	41.76%	38.23%	33.84%
SG&A Expenses to Revenue	22.49%	22.83%	26.96%	21.55%	18.95%	17.77%	19.03%	17.49%
R&D to Revenue	7.00%	5.28%	6.70%	6.24%	6.07%	8.15%	8.71%	8.19%
Operating Expenses to Revenue	78.80%	77.95%	92.49%	68.67%	72.13%	66.38%	62.86%	70.23%
Earnings before Interest and Taxes (EBIT)	319	46	-580	-25	-693	-191	70	-81
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	468	176	-385	125	-254	178	253	50
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	2.45	1.63	0.67	0.61	0.55	0.64
Price to Tangible Book Value (P/TBV)	0.00	0.00	3.56	4.62	2.28	1.71	1.02	1.22
Price to Revenue (P/Rev)	0.00	0.00	5.85	3.16	0.75	1.28	1.18	1.27
Price to Earnings (P/E)	0.00	0.00	59.91	19.59	0.00	14.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	20.18%
Earnings Yield	0.00%	0.00%	1.67%	5.10%	0.00%	7.14%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	3.45	1.61	0.56	0.42	0.46	0.30
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	4.98	3.22	0.48	0.59	0.46	0.31
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	95.55	0.00	9.61	4.81	14.88
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	17.40	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	121.43	100.17	0.00	22.10	6.32	12.03
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.99	6.66	0.87	5.42
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.08	0.10	0.27	0.31	0.30	0.23	0.30
Long-Term Debt to Equity	0.00	0.08	0.10	0.26	0.31	0.29	0.23	0.29
Financial Leverage	0.00	-0.31	-0.41	-0.25	-0.17	-0.36	-0.49	-0.54
Leverage Ratio	0.00	1.34	1.27	1.42	1.58	1.55	1.53	1.52
Compound Leverage Factor	0.00	1.00	-0.53	-41.01	3.48	-3.19	-15.68	1.53
Debt to Total Capital	0.00%	7.46%	8.80%	21.09%	23.70%	22.96%	18.91%	22.94%
Short-Term Debt to Total Capital	0.00%	0.42%	0.00%	0.30%	0.35%	0.34%	0.45%	0.39%
Long-Term Debt to Total Capital	0.00%	7.04%	8.80%	20.79%	23.35%	22.62%	18.46%	22.55%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	15.60%	9.70%	6.02%	7.72%	8.06%	9.34%	0.89%
Common Equity to Total Capital	0.00%	76.94%	81.50%	72.89%	68.58%	68.98%	71.75%	76.17%
Debt to EBITDA	0.00	1.40	-1.85	16.66	-8.07	11.38	5.82	28.77
Net Debt to EBITDA	0.00	-5.36	8.26	-3.13	8.28	-15.33	-10.26	-47.32
Long-Term Debt to EBITDA	0.00	1.32	-1.85	16.42	-7.96	11.21	5.68	28.27
Debt to NOPAT	0.00	18.01	-1.12	-18.71	-6.17	-11.34	-73.23	-20.91
Net Debt to NOPAT	0.00	-69.04	4.98	3.52	6.33	15.28	129.17	34.40
Long-Term Debt to NOPAT	0.00	17.00	-1.12	-18.44	-6.08	-11.17	-71.48	-20.55
Altman Z-Score	0.00	0.00	6.09	2.11	1.04	0.99	0.96	1.11
Noncontrolling Interest Sharing Ratio	0.00%	16.86%	12.45%	9.09%	8.77%	10.30%	10.98%	7.05%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.00	2.10	5.49	2.23	2.37	2.36	2.80	2.75
Quick Ratio	0.00	1.84	5.13	2.05	2.10	2.09	2.10	2.51
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-2,093	-2,528	-3,492	2,548	256	1,394	136
Operating Cash Flow to CapEx	675.63%	289.53%	186.71%	133.61%	-63.70%	120.46%	8,504.77%	3,515.61%
Free Cash Flow to Firm to Interest Expense	0.00	-175.84	-156.36	-101.92	23.13	1.87	10.27	1.13
Operating Cash Flow to Interest Expense	28.29	23.13	7.01	3.47	-0.75	0.56	1.42	0.51
Operating Cash Flow Less CapEx to Interest Expense	24.10	15.14	3.26	0.87	-1.93	0.10	1.40	0.50
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.61	0.42	0.34	0.46	0.28	0.26	0.28
Accounts Receivable Turnover	0.00	13.80	12.58	7.76	8.03	5.10	5.14	5.14
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	8.22	9.53	8.75	9.68	6.05	6.82	7.97
Accounts Payable Turnover	0.00	7.56	9.24	8.88	11.50	10.22	12.59	17.76
Days Sales Outstanding (DSO)	0.00	26.45	29.02	47.02	45.43	71.54	70.97	71.06
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	48.29	39.49	41.11	31.74	35.72	28.98	20.55
Cash Conversion Cycle (CCC)	0.00	-21.84	-10.48	5.91	13.70	35.83	41.99	50.51
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	0.00	2,107	3,996	7,378	4,497	4,062	2,648	2,444
Invested Capital Turnover	0.00	2.38	0.91	0.65	0.88	0.68	0.78	0.94
Increase / (Decrease) in Invested Capital	0.00	2,107	1,889	3,381	-2,881	-435	-1,414	-204
Enterprise Value (EV)	0.00	0.00	13,768	11,910	2,510	1,709	1,216	737
Market Capitalization	0.00	0.00	16,159	11,707	3,945	3,724	3,082	3,028
Book Value per Share	$0.00	$0.00	$77.31	$80.11	$66.76	$70.80	$64.66	$61.13
Tangible Book Value per Share	$0.00	$0.00	$53.23	$28.29	$19.49	$25.38	$35.12	$31.98
Total Capital	0.00	3,295	8,095	9,844	8,650	8,812	7,774	6,215
Total Debt	0.00	246	712	2,076	2,050	2,023	1,470	1,426
Total Long-Term Debt	0.00	232	712	2,046	2,020	1,993	1,435	1,401
Net Debt	0.00	-942	-3,177	-390	-2,103	-2,726	-2,593	-2,345
Capital Expenditures (CapEx)	55	95	61	89	130	64	2.26	1.74
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-182	-223	-414	-146	-126	252	48
Debt-free Net Working Capital (DFNWC)	0.00	658	3,368	1,725	1,511	1,320	1,634	1,008
Net Working Capital (NWC)	0.00	644	3,368	1,695	1,481	1,290	1,599	984
Net Nonoperating Expense (NNE)	-258	-19	-907	-700	860	-437	513	33
Net Nonoperating Obligations (NNO)	0.00	-942	-3,387	-390	-2,103	-2,726	-3,657	-2,345
Total Depreciation and Amortization (D&A)	149	130	196	150	439	369	183	131
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-7.26%	-8.06%	-11.19%	-2.78%	-4.33%	9.61%	2.01%
Debt-free Net Working Capital to Revenue	0.00%	26.20%	121.84%	46.62%	28.86%	45.22%	62.31%	42.14%
Net Working Capital to Revenue	0.00%	25.65%	121.84%	45.81%	28.29%	44.19%	60.98%	41.11%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$3.16	$6.70	($13.55)	$3.07	($6.49)	($1.30)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	88.77M	89.76M	88.87M	85.97M	83.28M	76.91M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$2.97	$6.31	($13.55)	$2.97	($6.49)	($1.30)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	88.77M	89.76M	88.87M	85.97M	83.28M	76.91M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	88.77M	89.76M	88.87M	85.97M	83.28M	76.91M
Normalized Net Operating Profit after Tax (NOPAT)	34	6.34	-191	-111	-253	-172	-20	77
Normalized NOPAT Margin	1.35%	0.25%	-6.90%	-3.00%	-4.84%	-5.88%	-0.77%	3.22%
Pre Tax Income Margin	12.06%	1.37%	8.83%	19.73%	-29.15%	13.46%	-27.27%	-3.42%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	24.40	3.88	-35.89	-0.74	-6.29	-1.39	0.51	-0.68
NOPAT to Interest Expense	2.63	1.15	-39.49	-3.24	-3.02	-1.30	-0.15	-0.57
EBIT Less CapEx to Interest Expense	20.21	-4.11	-39.65	-3.33	-7.47	-1.86	0.50	-0.69
NOPAT Less CapEx to Interest Expense	-1.56	-6.84	-43.24	-5.84	-4.20	-1.76	-0.16	-0.58
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	76.42%	1.59%	5.15%	-0.10%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	253.24%	25.30%	11.16%	-7.94%	64.12%	0.00%	-310.48%

This table displays calculated financial ratios and metrics derived from People Incorporated Common Stock's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	85,845,970.00	85,851,321.00	85,965,621.00	86,094,182.00	86,123,365.00	86,268,572.00	83,283,336.00	79,841,774.00	80,157,271.00	-	76,907,964.00
DEI Adjusted Shares Outstanding	85,845,970.00	85,851,321.00	85,965,621.00	86,094,182.00	86,123,365.00	86,268,572.00	83,283,336.00	79,841,774.00	80,157,271.00	-	76,907,964.00
DEI Earnings Per Adjusted Shares Outstanding	-4.55	3.82	0.52	-1.65	-2.83	-2.31	-2.60	2.65	-0.27	-	-0.93
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-14.57%	-131.11%	-42.42%	-42.93%	-42.23%	286.03%	-22.84%	-7.48%	-8.13%	-10.46%	-12.21%
EBITDA Growth	102.73%	131.26%	315.98%	46.08%	-27.43%	179.83%	300.04%	-53.28%	-109.93%	-159.01%	-99.42%
EBIT Growth	93.06%	88.03%	70.41%	164.36%	354.46%	302.69%	195.94%	-88.12%	-309.58%	-259.67%	-181.80%
NOPAT Growth	73.74%	79.24%	67.81%	61.26%	124.88%	408.32%	151.68%	102.94%	-350.41%	9,991.08%	-266.08%
Net Income Growth	-495.35%	3,266.44%	-89.17%	-54.39%	39.43%	-161.04%	-577.11%	248.89%	90.85%	61.99%	67.06%
EPS Growth	0.00%	0.00%	-88.84%	-59.81%	37.92%	-156.32%	-617.65%	250.29%	90.79%	59.32%	64.39%
Operating Cash Flow Growth	115.28%	-438.85%	59.85%	-80.67%	345.24%	204.46%	-106.70%	-113.82%	-52.95%	-46.40%	671.20%
Free Cash Flow Firm Growth	102.30%	-85.01%	1,530.41%	849.92%	5,449.38%	241.56%	-67.68%	-65.47%	-60.31%	148.70%	-36.16%
Invested Capital Growth	-1.11%	-9.67%	-46.69%	-45.97%	-43.12%	-34.82%	-27.58%	-29.23%	-30.53%	-7.71%	-25.74%
Revenue Q/Q Growth	-0.02%	-134.89%	-41.00%	1.62%	1.20%	12.37%	-33.23%	2.88%	0.49%	9.53%	-34.53%
EBITDA Q/Q Growth	72.36%	-60.13%	-87.55%	355.41%	-14.38%	53.73%	-33.26%	-55.93%	-118.19%	-813.84%	100.65%
EBIT Q/Q Growth	83.63%	-278.01%	0.55%	186.51%	-35.29%	201.10%	-43.08%	-92.17%	-1,241.23%	-129.40%	70.84%
NOPAT Q/Q Growth	40.99%	52.36%	-18.85%	53.96%	137.91%	490.30%	-49.83%	-98.23%	-3,326.44%	23,888.59%	-100.83%
Net Income Q/Q Growth	-327.83%	183.32%	-86.23%	-414.57%	-67.84%	16.03%	-7.61%	198.17%	-110.32%	-248.71%	6.77%
EPS Q/Q Growth	-341.12%	188.77%	-87.83%	-435.29%	-71.35%	19.45%	-11.86%	197.35%	-110.51%	-255.56%	2.08%
Operating Cash Flow Q/Q Growth	-86.04%	-553.95%	-14.19%	-50.47%	221.54%	6.51%	-103.95%	-2.19%	1,194.70%	21.33%	-57.93%
Free Cash Flow Firm Q/Q Growth	112.11%	722.77%	701.44%	-2.25%	-10.40%	-49.36%	-27.12%	3.62%	2.98%	217.33%	-81.29%
Invested Capital Q/Q Growth	-5.12%	-38.62%	-7.32%	0.09%	-0.12%	-29.65%	2.97%	-2.19%	-1.95%	-6.55%	-17.14%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	69.19%	0.00%	58.44%	60.06%	62.14%	65.83%	61.11%	65.59%	64.83%	69.80%	62.22%
EBITDA Margin	7.91%	0.00%	2.62%	11.74%	9.93%	13.59%	13.58%	5.93%	-1.07%	-8.95%	0.09%
Operating Margin	-2.95%	0.00%	-10.16%	-3.39%	1.27%	6.67%	5.01%	0.10%	-3.46%	-17.55%	-9.47%
EBIT Margin	-0.66%	0.00%	-5.30%	4.51%	2.89%	7.73%	6.59%	0.58%	-6.58%	-13.79%	-6.14%
Profit (Net Income) Margin	-35.27%	0.00%	7.20%	-22.30%	-36.99%	-27.64%	-44.55%	35.89%	-3.69%	-11.73%	-16.71%
Tax Burden Percent	76.74%	70.25%	46.86%	76.42%	65.52%	75.67%	66.88%	76.97%	44.36%	-2,997.15%	396.35%
Interest Burden Percent	7,015.38%	-1,689.23%	-289.94%	-646.52%	-1,955.74%	-472.25%	-1,010.28%	8,042.11%	126.16%	-2.84%	68.64%
Effective Tax Rate	0.00%	21.89%	48.48%	0.00%	0.00%	0.00%	0.00%	23.03%	0.00%	3,096.13%	0.00%
Return on Invested Capital (ROIC)	-1.41%	0.00%	-3.78%	-1.51%	0.51%	3.65%	2.68%	0.09%	-2.77%	494.33%	-6.52%
ROIC Less NNEP Spread (ROIC-NNEP)	-253.43%	0.00%	-9.00%	7.53%	19.59%	10.95%	11.72%	-7.92%	-2.47%	610.03%	-4.67%
Return on Net Nonoperating Assets (RNNOA)	-5.70%	0.00%	1.94%	-1.56%	-3.86%	-5.34%	-5.17%	3.56%	1.08%	-330.06%	2.30%
Return on Equity (ROE)	-7.11%	0.00%	-1.84%	-3.07%	-3.35%	-1.69%	-2.49%	3.64%	-1.69%	164.27%	-4.22%
Cash Return on Invested Capital (CROIC)	-2.03%	5.99%	58.47%	57.67%	53.44%	41.56%	33.26%	36.78%	37.97%	5.34%	25.25%
Operating Return on Assets (OROA)	-0.29%	0.00%	-1.96%	1.49%	0.86%	2.02%	1.86%	0.24%	-2.83%	-3.92%	-2.05%
Return on Assets (ROA)	-15.70%	0.00%	2.66%	-7.37%	-11.02%	-7.23%	-12.59%	15.14%	-1.58%	-3.34%	-5.57%
Return on Common Equity (ROCE)	-6.36%	0.00%	-1.65%	-2.75%	-2.98%	-1.51%	-2.33%	3.40%	-1.58%	152.69%	-4.18%
Return on Equity Simple (ROE_SIMPLE)	-1.37%	0.00%	-1.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-23	-11	-33	-15	5.70	34	17	0.44	-14	3,397	-28
NOPAT Margin	-2.06%	0.00%	-5.23%	-2.37%	0.89%	4.67%	3.51%	0.08%	-2.42%	525.82%	-6.63%
Net Nonoperating Expense Percent (NNEP)	252.01%	13.98%	5.23%	-9.05%	-19.09%	-7.30%	-9.04%	8.00%	-0.30%	-115.71%	-1.85%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.12%	-0.37%	-0.17%	0.07%	0.43%	0.27%	0.01%	-0.23%	54.88%	-0.47%
Cost of Revenue to Revenue	30.81%	0.00%	41.56%	39.94%	37.86%	34.17%	38.89%	34.41%	35.17%	30.20%	37.78%
SG&A Expenses to Revenue	18.94%	0.00%	20.42%	19.86%	16.95%	18.96%	9.03%	19.99%	22.44%	16.41%	24.62%
R&D to Revenue	7.17%	0.00%	10.13%	8.41%	8.40%	8.01%	7.42%	8.49%	8.39%	7.20%	9.39%
Operating Expenses to Revenue	72.14%	0.00%	68.60%	63.45%	60.87%	59.16%	56.10%	65.49%	68.28%	87.35%	71.69%
Earnings before Interest and Taxes (EBIT)	-7.28	-28	-33	29	19	56	32	3.40	-39	-89	-26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	88	35	16	74	64	98	65	35	-6.33	-58	0.38
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.75	0.61	0.62	0.56	0.67	0.55	0.67	0.61	0.57	0.64	0.68
Price to Tangible Book Value (P/TBV)	2.52	1.71	1.57	1.43	1.81	1.02	1.45	1.24	1.18	1.22	1.15
Price to Revenue (P/Rev)	0.95	1.28	0.97	0.97	1.30	1.18	1.28	0.80	0.75	1.27	1.32
Price to Earnings (P/E)	0.00	14.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	75.28
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	21.14%	23.17%	20.18%	19.72%
Earnings Yield	0.00%	7.14%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.33%
Enterprise Value to Invested Capital (EV/IC)	0.79	0.42	0.38	0.29	0.49	0.46	0.43	0.28	0.21	0.30	0.27
Enterprise Value to Revenue (EV/Rev)	1.14	0.59	0.37	0.32	0.62	0.46	0.48	0.20	0.15	0.31	0.24
Enterprise Value to EBITDA (EV/EBITDA)	169.44	9.61	4.99	3.55	6.44	4.81	3.92	1.81	1.65	14.88	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	17.40	8.77	4.49	5.21	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	28.68	9.00	8.97	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	32.13	22.10	6.99	9.06	10.77	6.32	7.90	2.55	2.18	12.03	6.98
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	6.66	0.45	0.36	0.66	0.87	1.09	0.62	0.46	5.42	0.92
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.31	0.30	0.29	0.30	0.31	0.23	0.31	0.29	0.30	0.30	0.31
Long-Term Debt to Equity	0.31	0.29	0.29	0.29	0.30	0.23	0.30	0.28	0.29	0.29	0.30
Financial Leverage	0.02	-0.36	-0.22	-0.21	-0.20	-0.49	-0.44	-0.45	-0.44	-0.54	-0.49
Leverage Ratio	1.57	1.55	1.53	1.53	1.54	1.53	1.51	1.50	1.50	1.52	1.50
Compound Leverage Factor	110.27	-26.20	-4.44	-9.91	-30.03	-7.24	-15.27	120.86	1.90	-0.04	1.03
Debt to Total Capital	23.95%	22.96%	22.74%	23.01%	23.60%	18.91%	23.49%	22.41%	22.79%	22.94%	23.61%
Short-Term Debt to Total Capital	0.35%	0.34%	0.39%	0.44%	0.51%	0.45%	0.68%	0.33%	0.36%	0.39%	0.41%
Long-Term Debt to Total Capital	23.59%	22.62%	22.36%	22.57%	23.10%	18.46%	22.81%	22.08%	22.43%	22.55%	23.21%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	8.32%	8.06%	8.08%	8.21%	8.52%	9.34%	0.79%	0.81%	0.85%	0.89%	0.75%
Common Equity to Total Capital	67.73%	68.98%	69.17%	68.78%	67.87%	71.75%	75.72%	76.78%	76.36%	76.17%	75.64%
Debt to EBITDA	66.11	11.38	7.04	6.48	7.01	5.82	4.85	3.52	4.24	28.77	-91.81
Net Debt to EBITDA	5.59	-15.33	-10.76	-9.54	-9.51	-10.26	-6.75	-5.64	-6.62	-47.32	166.12
Long-Term Debt to EBITDA	65.13	11.21	6.92	6.36	6.85	5.68	4.71	3.47	4.18	28.27	-90.22
Debt to NOPAT	-9.70	-11.34	-15.28	-18.57	-25.16	-73.23	35.48	17.50	23.08	-20.91	-13.95
Net Debt to NOPAT	-0.82	15.28	23.37	27.32	34.16	129.17	-49.42	-28.03	-35.98	34.40	25.23
Long-Term Debt to NOPAT	-9.56	-11.17	-15.01	-18.21	-24.62	-71.48	34.45	17.24	22.71	-20.55	-13.70
Altman Z-Score	1.28	1.05	1.19	1.08	1.13	0.96	1.17	1.32	1.23	1.11	1.21
Noncontrolling Interest Sharing Ratio	10.54%	0.00%	10.13%	10.43%	11.05%	10.98%	6.60%	6.58%	6.85%	7.05%	1.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.16	2.36	2.70	2.68	2.75	2.80	2.70	2.87	2.56	2.75	3.69
Quick Ratio	1.90	2.09	2.46	2.46	2.54	2.10	2.47	2.63	2.37	2.51	3.43
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	52	424	3,265	3,191	2,859	1,448	1,055	1,102	1,135	3,601	674
Operating Cash Flow to CapEx	78.34%	0.00%	0.00%	595.34%	1,881.64%	1,299.52%	-65.14%	-63.46%	3,461.31%	0.00%	193.29%
Free Cash Flow to Firm to Interest Expense	1.28	21.10	94.14	92.57	82.50	45.38	37.27	29.65	41.06	133.81	26.05
Operating Cash Flow to Interest Expense	0.36	-3.25	1.16	0.58	1.85	2.14	-0.10	-0.07	1.09	1.36	0.60
Operating Cash Flow Less CapEx to Interest Expense	-0.10	-1.59	1.44	0.48	1.75	1.97	-0.24	-0.19	1.06	1.66	0.29
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.45	0.28	0.37	0.33	0.30	0.26	0.28	0.42	0.43	0.28	0.33
Accounts Receivable Turnover	8.23	5.10	7.80	6.78	5.93	5.14	5.80	8.56	8.35	5.14	6.48
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	8.57	6.05	8.81	7.59	6.73	6.82	6.77	10.38	10.44	7.97	7.87
Accounts Payable Turnover	9.79	10.22	12.68	11.34	9.48	12.59	14.22	15.30	14.96	17.76	18.89
Days Sales Outstanding (DSO)	44.36	71.54	46.81	53.85	61.50	70.97	62.97	42.65	43.71	71.06	56.33
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	37.28	35.72	28.79	32.18	38.51	28.98	25.67	23.86	24.39	20.55	19.32
Cash Conversion Cycle (CCC)	7.08	35.83	18.03	21.67	22.99	41.99	37.30	18.79	19.32	50.51	37.01
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	6,617	4,062	3,765	3,768	3,764	2,648	2,726	2,667	2,615	2,444	2,025
Invested Capital Turnover	0.68	0.68	0.72	0.64	0.57	0.78	0.76	1.15	1.15	0.94	0.98
Increase / (Decrease) in Invested Capital	-74	-435	-3,297	-3,206	-2,854	-1,414	-1,038	-1,101	-1,149	-204	-702
Enterprise Value (EV)	5,202	1,709	1,430	1,100	1,843	1,216	1,182	737	555	737	554
Market Capitalization	4,326	3,724	3,798	3,341	3,839	3,082	3,169	2,981	2,731	3,028	3,079
Book Value per Share	$66.87	$70.80	$71.34	$69.79	$66.88	$64.66	$56.60	$61.51	$59.76	$61.13	$59.15
Tangible Book Value per Share	$20.03	$25.38	$28.19	$27.14	$24.62	$35.12	$26.29	$30.19	$28.86	$31.98	$34.67
Total Capital	8,476	8,812	8,866	8,735	8,486	7,774	6,225	6,396	6,273	6,215	6,015
Total Debt	2,030	2,023	2,017	2,010	2,003	1,470	1,462	1,433	1,430	1,426	1,420
Total Long-Term Debt	2,000	1,993	1,982	1,971	1,960	1,435	1,420	1,412	1,407	1,401	1,396
Net Debt	172	-2,726	-3,085	-2,957	-2,719	-2,593	-2,036	-2,296	-2,229	-2,345	-2,570
Capital Expenditures (CapEx)	18	-33	-9.74	3.35	3.41	5.25	4.14	4.34	0.87	-7.99	7.96
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-207	-126	-153	-167	-175	252	-51	-30	-59	48	43
Debt-free Net Working Capital (DFNWC)	1,219	1,320	1,490	1,522	1,570	1,634	1,109	1,064	947	1,008	1,155
Net Working Capital (NWC)	1,189	1,290	1,456	1,483	1,526	1,599	1,066	1,043	924	984	1,131
Net Nonoperating Expense (NNE)	369	-338	-78	126	243	233	231	-210	7.46	3,472	43
Net Nonoperating Obligations (NNO)	172	-2,726	-3,085	-2,957	-2,719	-3,657	-2,036	-2,296	-2,229	-2,345	-2,570
Total Depreciation and Amortization (D&A)	95	63	49	46	45	42	34	31	33	31	26
Debt-free, Cash-free Net Working Capital to Revenue	-4.55%	-4.33%	-3.93%	-4.87%	-5.92%	9.61%	-2.04%	-0.81%	-1.61%	2.01%	1.84%
Debt-free Net Working Capital to Revenue	26.77%	45.22%	38.16%	44.40%	53.05%	62.31%	44.71%	28.71%	25.91%	42.14%	49.49%
Net Working Capital to Revenue	26.11%	44.19%	37.28%	43.27%	51.59%	60.98%	43.01%	28.14%	25.28%	41.11%	48.44%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$4.14	$0.52	($1.71)	($2.93)	($2.37)	($2.64)	$2.64	($0.27)	($1.03)	($0.94)
Adjusted Weighted Average Basic Shares Outstanding	85.85M	85.97M	86.09M	86.12M	86.27M	83.28M	79.84M	80.16M	77.43M	76.91M	74.38M
Adjusted Diluted Earnings per Share	$0.00	$4.19	$0.51	($1.71)	($2.93)	($2.36)	($2.64)	$2.57	($0.27)	($0.96)	($0.94)
Adjusted Weighted Average Diluted Shares Outstanding	85.85M	85.97M	86.09M	86.12M	86.27M	83.28M	79.84M	80.16M	77.43M	76.91M	74.38M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	85.85M	85.97M	86.09M	86.12M	86.27M	83.28M	79.84M	80.16M	77.43M	76.91M	74.38M
Normalized Net Operating Profit after Tax (NOPAT)	-17	-11	-33	-15	5.70	34	17	0.44	-14	-79	-28
Normalized NOPAT Margin	-1.50%	0.00%	-5.23%	-2.37%	0.89%	4.67%	3.51%	0.08%	-2.42%	-12.29%	-6.63%
Pre Tax Income Margin	-45.97%	0.00%	15.37%	-29.18%	-56.45%	-36.52%	-66.60%	46.63%	-8.31%	0.39%	-4.22%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.18	-1.37	-0.95	0.83	0.53	1.75	1.12	0.09	-1.41	-3.31	-1.00
NOPAT to Interest Expense	-0.57	-0.54	-0.94	-0.44	0.16	1.05	0.60	0.01	-0.52	126.22	-1.08
EBIT Less CapEx to Interest Expense	-0.64	0.29	-0.67	0.73	0.44	1.58	0.98	-0.03	-1.44	-3.01	-1.31
NOPAT Less CapEx to Interest Expense	-1.03	1.12	-0.66	-0.53	0.07	0.89	0.45	-0.10	-0.55	126.52	-1.39
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-214.90%	64.12%	-81.97%	-4.66%	-103.36%	0.00%	-22.63%	-51.86%	-146.01%	-310.48%	610.97%

Financials Breakdown Chart

Key Financial Trends

People Incorporated Common Stock (NASDAQ:PPLI) showed a much stronger operating profile in Q1 2026 than in the prior quarter, but the bigger story remains the company’s uneven earnings history and the impact of large portfolio/transaction items.

Operating cash flow improved sharply year over year. Q1 2026 net cash from operating activities was $15.4 million, up from a negative $2.8 million in Q2 2025 and negative $27.3 million in Q1 2025.
Core continuing operations turned positive on a cash basis. Net cash from continuing operating activities was $10.0 million in Q1 2026, versus negative $75.8 million in Q4 2025 and negative $258.3 million in Q1 2025.
Revenue grew sequentially from the prior quarter. Q1 2026 operating revenue was $422.9 million, up from $646.0 million in Q4 2025 but still well above the weaker 2025 and 2024 comparisons; the quarter also produced a sizable gross profit of $263.1 million.
The balance sheet remains liquid. Cash and equivalents stood at $1.11 billion at the end of Q1 2026, providing a meaningful cushion despite ongoing losses.
Equity remains substantial. Total common equity was $4.55 billion, indicating the company still has a sizeable capital base.
Debt levels appear manageable relative to assets. Total debt consisted of $24.5 million in short-term debt and $1.40 billion in long-term debt, against $6.82 billion in total assets.
Investing cash flow was heavily boosted by divestitures. Q1 2026 net cash from investing activities was $260.6 million, driven largely by $303.2 million of divestiture proceeds, which may not recur.
Q1 2026 earnings were still negative, but much improved versus recent losses. Consolidated net loss was $70.7 million, compared with a $75.8 million loss in Q4 2025 and a $214.6 million loss in Q1 2025.
Share count has been trending lower. Weighted average diluted shares were 74.4 million in Q1 2026, down from 76.9 million in Q4 2025 and 79.8 million in Q1 2025.
Margins remain under pressure. Q1 2026 operating expenses of $303.2 million exceeded gross profit, resulting in an operating loss of $40.1 million.
Marketing and SG&A remain very high relative to revenue. In Q1 2026, marketing expense was $133.0 million and SG&A was $104.1 million, keeping profitability under strain.
Interest and other below-the-line costs still weigh on results. Interest expense was $25.9 million in Q1 2026, and the company also reported significant non-operating items and discontinued operations losses.
Longer-term trend shows volatility in profitability. The company swung from positive net income in Q2 2025 to losses in Q3 2025, Q4 2025, and Q1 2026, making earnings consistency a concern.

Bottom line: Q1 2026 looks better on operating cash flow and liquidity than the recent quarters, but the business is still not consistently profitable and depends on large non-operating and divestiture-related items. For retail investors, the key question is whether the recent cash flow improvement is sustainable once transaction-driven benefits fade.

06/06/26 09:45 AM ETAI Generated. May Contain Errors.

People Incorporated Common Stock Financials - Frequently Asked Questions

According to the most recent income statement we have on file, People Incorporated Common Stock's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

People Incorporated Common Stock's net income appears to be on an upward trend, with a most recent value of -$101.47 million in 2025, falling from $292.37 million in 2018. The previous period was -$533.33 million in 2024. Find out what analysts predict for People Incorporated Common Stock in the coming months.

People Incorporated Common Stock's total operating income in 2025 was -$97.42 million, based on the following breakdown:

Total Gross Profit: $1.58 billion
Total Operating Expenses: $1.68 billion

Over the last 7 years, People Incorporated Common Stock's total revenue changed from $2.53 billion in 2018 to $2.39 billion in 2025, a change of -5.5%.

People Incorporated Common Stock's total liabilities were at $2.41 billion at the end of 2025, a 28.9% decrease from 2024, and a 129.5% increase since 2019.

In the past 6 years, People Incorporated Common Stock's cash and equivalents has ranged from $839.80 million in 2019 to $3.37 billion in 2020, and is currently $941.31 million as of their latest financial filing in 2025.

Over the last 7 years, People Incorporated Common Stock's book value per share changed from 0.00 in 2018 to 61.13 in 2025, a change of 6,113.5%.

Related Companies

Financial statements for NASDAQ:PPLI last updated on 6/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

People Incorporated Common Stock (PPLI) Financials

Financials Breakdown Chart

Key Financial Trends

People Incorporated Common Stock Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

People Incorporated Common Stock (PPLI) Financials

Annual Income Statements for People Incorporated Common Stock

Quarterly Income Statements for People Incorporated Common Stock

Annual Cash Flow Statements for People Incorporated Common Stock

Quarterly Cash Flow Statements for People Incorporated Common Stock

Annual Balance Sheets for People Incorporated Common Stock

Quarterly Balance Sheets for People Incorporated Common Stock

Annual Metrics And Ratios for People Incorporated Common Stock

Quarterly Metrics And Ratios for People Incorporated Common Stock

Financials Breakdown Chart

Key Financial Trends

People Incorporated Common Stock Financials - Frequently Asked Questions

When does People Incorporated Common Stock's financial year end?

How has People Incorporated Common Stock's net income changed over the last 7 years?

What is People Incorporated Common Stock's operating income?

How has People Incorporated Common Stock's revenue changed over the last 7 years?

How much debt does People Incorporated Common Stock have?

How much cash does People Incorporated Common Stock have?

How has People Incorporated Common Stock's book value per share changed over the last 7 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools